Determination of lower cut‐off levels of adalimumab associated with biochemical remission in Crohn's disease

BACKGROUND AND AIM: Adalimumab is administered and dosed using a standardized treatment regimen. Although therapeutic drug monitoring (TDM) may help optimize treatment efficacy, the lower cut‐off concentration of adalimumab needed to retain disease remission has not been established. This cross‐sect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Carlsen, Arne, Omdal, Roald, Karlsen, Lars, Kvaløy, Jan Terje, Aabakken, Lars, Steinsbø, Øyvind, Bolstad, Nils, Warren, David, Lundin, Knut Erik Aslaksen, Grimstad, Tore
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273736/
https://ncbi.nlm.nih.gov/pubmed/32514446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados